*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Eli/NNP Lilly/NNP ]
&/CC 
[ Co./NNP ]
said/VBD that/IN on/IN 
[ Nov./NNP 6/CD it/PRP ]
will/MD redeem/VB 
[ all/DT $/$ 40.7/CD million/CD ]
of/IN 
[ its/PRP$ 6/CD 3\/4/CD %/NN convertible/JJ notes/NNS due/JJ 1996/CD ]
./. 

======================================

[ The/DT pharmaceuticals/NNS concern/NN ]
said/VBD 
[ the/DT notes/NNS ]
will/MD be/VB redeemed/VBN at/IN 
[ a/DT price/NN ]
of/IN 
[ 104.725/CD ]
plus/CC accrued/JJ but/CC 
[ unpaid/JJ interest/NN ]
to/TO 
[ the/DT redemption/NN date/NN ]
./. 

[ The/DT notes/NNS ]
are/VBP convertible/JJ at/IN 
[ the/DT holder/NN 's/POS option/NN ]
into/IN Lilly/NNP 
[ common/JJ stock/NN ]
at/IN 
[ a/DT price/NN ]
of/IN 
[ $/$ 33.155/CD ]

[ a/DT share/NN ]
./. 

======================================

Lilly/NNP has/VBZ 
[ 277.6/CD million/CD common/JJ shares/NNS ]
outstanding/JJ ./. 
